INS and type 2 diabetes mellitus: Treatment with GLP-1RA, SGLT-2i, and their combination within 12 months showed a greater improvement of vascular markers and effective cardiac work than insulin treatment in T2DM. The combined therapy was superior to either insulin or GLP- 1RA and SGLT-2i separately.